Literature DB >> 11045897

A post-ischaemic single administration of galanthamine, a cholinesterase inhibitor, improves learning ability in rats.

A I Iliev1, V B Traykov, G T Mantchev, I Stoykov, D Prodanov, K S Yakimova, I M Krushkov.   

Abstract

Transient forebrain ischaemia is widely observed in clinical practice. We have examined the effect of a single administration of the cholinesterase inhibitor galanthamine (2mg kg(-1) i.p.) 25 min after reperfusion in male Sprague-Dawley rats (180 +/- 20 g) after a 20-min common carotid artery occlusion. Twenty-four-hours post-ischaemia there was no difference in motor co-ordination or muscle tonus of the rats treated with or without galanthamine as assessed by the rota-rod test. Learning ability was examined using the shuttle-box test, evaluating the latency time and the number of errors for six days in succession. The performance of the ischaemic saline-injected rats was significantly impaired on days 4, 5, 6 (latency time) compared with the non-ischaemic rats and with the ischaemic animals administered galanthamine (P < 0.05). Similar results were obtained when counting the number of errors (failure to cross the cage during conditioned or unconditioned stimulus). The monitoring of body temperature during the first 12-h post-ischaemia did not show any significant difference between the groups. The data showed a beneficial effect of galanthamine on the recovery of learning ability when administered once only post-ischaemia. This suggests a direct effect on the early pathologic mechanisms of CNS damage. Cholinesterase inhibitors may prove useful in the early clinical treatment of ischaemic conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045897     DOI: 10.1211/0022357001774921

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.

Authors:  Derek S Wilkinson; Thomas J Gould
Journal:  Behav Brain Res       Date:  2011-04-14       Impact factor: 3.332

2.  Galantamine and Environmental Enrichment Enhance Cognitive Recovery after Experimental Traumatic Brain Injury But Do Not Confer Additional Benefits When Combined.

Authors:  Patricia B de la Tremblaye; Corina O Bondi; Naima Lajud; Jeffrey P Cheng; Hannah L Radabaugh; Anthony E Kline
Journal:  J Neurotrauma       Date:  2016-12-20       Impact factor: 5.269

Review 3.  Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.

Authors:  Juan Wang; Hai-Yan Zhang; Xi-Can Tang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

4.  Pharmacological investigations of new galantamine peptide esters.

Authors:  Dobrina Tsvetkova; Nikolai Danchev; Irina Nikolova; Danka Obreshkova
Journal:  Biotechnol Biotechnol Equip       Date:  2014-01-02       Impact factor: 1.632

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.